We are live on ! Find out more
MIM

Meros Investment Management Portfolio holdings

AUM $231M
1-Year Est. Return 35.94%
This Fund
S&P 500
This Quarter Est. Return
+19.45%
1 Year Est. Return
+35.94%
3 Year Est. Return
+52.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$211M
AUM Growth
+$40.4M
Cap. Flow
+$23.5M
Cap. Flow %
11.15%
Top 10 Hldgs %
46.45%
Holding
44
New
3
Increased
34
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
PHR icon
Phreesia
PHR
+$3.12M
2
SEMR
Semrush
SEMR
+$2.31M
3
WS icon
Worthington Steel
WS
+$2.02M
4
INMD icon
InMode
INMD
+$1.86M
5
MDXG icon
MiMedx Group
MDXG
+$1.64M

Top Sells

Rank Stock Value
1
ANIK icon
Anika Therapeutics
ANIK
+$2.61M
2
CMCO icon
Columbus McKinnon
CMCO
+$2.09M
3
AMWD
American Woodmark
AMWD
+$1.76M
4
DCO icon
Ducommun
DCO
+$1.18M
5
MGNI icon
Magnite
MGNI
+$697K

Sector Composition

Rank Sector Weight
1 Industrials 25.37%
2 Technology 19.84%
3 Healthcare 14.48%
4 Consumer Discretionary 12.47%
5 Communication Services 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMBC icon
26
Embecta
EMBC
$262M
$4.02M 1.91%
415,332
+75,926
+22% +$854K
PACK icon
27
Ranpak Holdings
PACK
$473M
$3.83M 1.82%
1,073,588
+140,016
+15% +$519K
PHR icon
28
Phreesia
PHR
$773M
$3.5M 1.66%
+123,087
New +$3.12M
MLAB icon
29
Mesa Laboratories
MLAB
$574M
$3.45M 1.64%
36,618
+4,654
+15% +$511K
BLFS icon
30
BioLife Solutions
BLFS
$1.7B
$3.27M 1.55%
151,687
+20,037
+15% +$452K
TEAD
31
Teads Holding Co
TEAD
$67.7M
$3.06M 1.45%
1,234,208
+228,718
+23% +$692K
KRMD icon
32
KORU Medical Systems
KRMD
$164M
$3.04M 1.44%
850,390
+103,826
+14% +$295K
CVEO icon
33
Civeo
CVEO
$318M
$2.97M 1.41%
128,634
+21,581
+20% +$456K
SEMR
34
DELISTED
Semrush
SEMR
$2.33M 1.11%
257,370
+238,825
+1,288% +$2.31M
ASLE icon
35
AerSale
ASLE
$279M
$2.27M 1.08%
378,395
+48,826
+15% +$313K
NTIC icon
36
Northern Technologies International Corp
NTIC
$80M
$2.12M 1%
285,465
+35,952
+14% +$275K
JBI icon
37
Janus International
JBI
$757M
$1.17M 0.56%
+144,164
New +$1.1M
MASS icon
38
908 Devices
MASS
$364M
$495K 0.24%
+69,470
New +$386K
SRTS icon
39
Sensus Healthcare
SRTS
$50.5M
$470K 0.22%
99,212
+10,734
+12% +$50.3K
HBIO icon
40
Harvard Bioscience
HBIO
$29.2M
$408K 0.19%
91,995
+12,527
+16% +$52.3K
VSXY
41
Victoria's Secret
VSXY
$7.83B
$171K 0.08%
9,214
+1,271
+16% +$24.9K
AMWD
42
DELISTED
American Woodmark
AMWD
– –
-30,000
Closed -$1.76M
ANIK icon
43
Anika Therapeutics
ANIK
$287M
– –
-173,489
Closed -$2.61M
CMCO icon
44
Columbus McKinnon
CMCO
$584M
– –
-123,373
Closed -$2.09M
1
2

Similar funds

YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
PWA
Prairie Wealth Advisors Omaha, Nebraska $231M AUM 23.67% 1-Year Est. Return
RF
rebel Financial Groveport, Ohio $231M AUM 12.5% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
WF
Wayfinding Financial Lynnwood, Washington $230M AUM 17.64% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
TRIA
Trail Ridge Investment Advisors Fort Collins, Colorado $230M AUM 22.34% 1-Year Est. Return
TW
Titan Wealth St Peter Port $232M AUM

Meros Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Meros Investment Management held 44 positions worth $211M, up 24% from $170M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Meros Investment Management deployed $23.5M of net new capital in Q2 2025, opening 3 new positions and adding to 34 existing holdings. Its largest new stake was Phreesia: 123,087 shares worth $3.5M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Ducommun, an estimated $1.18M trimmed.

  • Meros Investment Management's largest Q2 2025 buy was Phreesia: 123,087 shares worth $3.5M.
  • Meros Investment Management added most to Semrush in Q2 2025, an estimated $2.31M increase.
  • Meros Investment Management's biggest Q2 2025 reduction was Ducommun, cutting an estimated $1.18M.
  • Meros Investment Management fully exited Anika Therapeutics in Q2 2025, selling an estimated $2.61M.
  • Meros Investment Management's ten largest holdings make up 46% of its $211M portfolio in Q2 2025.
  • Meros Investment Management opened 3 new positions and closed 3 in Q2 2025.
  • Meros Investment Management's portfolio value rose 24% quarter-over-quarter to $211M.

Based on Meros Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.